DePuy Synthes Appoints Christina Zamarro as Chief Financial Officer to Support Continued Global Growth
DePuy Synthes, a global leader in orthopaedic technologies and solutions, has announced the appointment of Christina Zamarro as its new Chief Financial Officer (CFO), effective July 13, 2026. The appointment brings an accomplished financial executive with more than 25 years of leadership experience to the company’s executive team as it continues to strengthen its position in the global orthopaedic and medical technology markets.
Zamarro joins DePuy Synthes after serving as Chief Financial Officer of The Goodyear Tire & Rubber Company, where she played a key role in overseeing the company’s global financial operations and supporting strategic initiatives. Her appointment reflects DePuy Synthes’ commitment to attracting experienced leaders capable of guiding the organization through continued growth, operational excellence, and long-term value creation.
Bringing Extensive Financial Leadership Experience
Christina Zamarro has built a distinguished career spanning more than two decades in finance, holding senior leadership positions across a broad range of financial disciplines. Her professional experience includes expertise in corporate treasury, investor relations, financial planning and analysis (FP&A), accounting, capital markets, liquidity management, and enterprise financial strategy.
Throughout her career, she has successfully managed complex financial organizations while helping large multinational companies navigate changing market conditions, execute transformation programs, and improve business performance.
Her experience leading financial operations across global organizations is expected to strengthen DePuy Synthes as the company continues expanding its portfolio of innovative orthopaedic technologies and solutions designed to improve patient outcomes worldwide.
Transition from Goodyear
Before joining DePuy Synthes, Zamarro served as Chief Financial Officer at The Goodyear Tire & Rubber Company, one of the world’s largest tire manufacturers with operations spanning numerous international markets.
In that role, she was responsible for overseeing the company’s financial strategy, capital allocation, financial reporting, and operational performance while supporting major business initiatives.
Her leadership contributed to managing financial complexity across a large global manufacturing organization, providing valuable experience that aligns well with the operational scale and international presence of DePuy Synthes.
The transition from a major industrial manufacturer to one of the world’s leading orthopaedic technology companies demonstrates the broad applicability of her financial expertise across highly regulated and globally competitive industries.
Supporting DePuy Synthes’ Strategic Vision
DePuy Synthes continues to invest in innovation, digital technologies, advanced surgical solutions, and operational excellence as it seeks to address the evolving needs of healthcare providers and patients worldwide.
As Chief Financial Officer, Zamarro will oversee the company’s global finance organization and help guide financial planning, resource allocation, and long-term strategic investments.
Her responsibilities are expected to include supporting business growth initiatives, strengthening financial performance, driving operational efficiency, and ensuring disciplined capital management while partnering closely with the company’s executive leadership team.
The appointment comes at a time when medical technology companies are increasingly investing in innovation, global expansion, and digital transformation to meet rising demand for advanced orthopaedic care.
Leadership Welcomes New CFO
Namal Nawana, Worldwide President of DePuy Synthes, welcomed Zamarro to the organization and highlighted the depth of experience she brings to the executive leadership team.
He noted that her extensive background in financial leadership and experience managing complex global transformation initiatives make her well positioned to support the company’s continued momentum.
According to Nawana, her expertise will be valuable as DePuy Synthes continues executing its long-term strategy focused on innovation, operational excellence, and sustainable growth.
He also expressed enthusiasm about working closely with Zamarro as the company advances its mission of delivering innovative orthopaedic solutions that improve patient care around the world.
Broad Expertise Across Financial Functions
One of Zamarro’s distinguishing strengths is the breadth of her financial leadership experience.
During her career, she has held executive positions across virtually every major area of corporate finance.
Her responsibilities have included overseeing:
- Treasury operations
- Capital markets strategy
- Liquidity management
- Financial risk management
- Investor relations
- Enterprise financial planning and analysis
- Performance management
- Corporate accounting
This broad background has provided her with experience balancing short-term operational priorities while supporting long-term strategic decision-making.
Her ability to integrate financial planning with broader business objectives has been a hallmark of her leadership throughout her career.
Experience Leading Business Transformation
In addition to traditional finance leadership, Zamarro has played an important role in managing organizational transformation initiatives.
Large multinational organizations frequently rely on experienced financial executives to help guide operational improvements, optimize capital allocation, and support strategic investments during periods of change.
Her experience leading complex transformation programs is expected to help DePuy Synthes continue enhancing its global operations while maintaining strong financial discipline.
As healthcare systems increasingly emphasize value-based care, efficiency, and technological innovation, experienced financial leadership will remain essential to supporting sustainable growth.
Strong Educational Background
Zamarro’s academic credentials complement her extensive executive experience.
She earned a Master of Business Administration (MBA) from Vanderbilt University, one of the leading graduate business schools in the United States.
She also holds a Bachelor of Arts in Economics from Ohio Wesleyan University, providing a strong foundation in economics, finance, and business strategy.
Her educational background has supported a career marked by progressive leadership responsibilities across multiple financial disciplines.
Public Company Board Experience
Beyond her executive responsibilities, Zamarro also serves as a member of the Board of Directors of L3Harris Technologies, a global aerospace and defense technology company.
In her role as a board director, she serves on the company’s Audit Committee, contributing oversight of financial reporting, internal controls, risk management, and corporate governance.
Her board experience provides additional perspective on strategic decision-making, governance best practices, and regulatory oversight, which may further strengthen her contributions as Chief Financial Officer of DePuy Synthes.
Christina Zamarro’s appointment marks an important addition to DePuy Synthes’ executive leadership team as the company continues pursuing innovation and growth in the global orthopaedic market. Bringing more than 25 years of financial leadership experience across treasury, investor relations, financial planning, accounting, and corporate transformation, she is well positioned to help guide the company’s financial strategy during its next phase of development.
With experience leading finance organizations at large multinational companies, combined with public company board service and a proven track record of managing complex global operations, Zamarro is expected to play a key role in supporting DePuy Synthes’ strategic priorities. As she assumes the role of Chief Financial Officer in July 2026, the company aims to build on its momentum while continuing to deliver innovative orthopaedic technologies and solutions that improve outcomes for patients and healthcare providers around the world.
About DePuy Synthes
DePuy Synthes provides one of the most comprehensive orthopaedics portfolios in the world that helps heal and restore movement to the millions of patients we serve. Our solutions—including joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery, and sports medicine—alongside the VELYS™ Digital Surgery portfolio, are designed to support improved patient care and deliver clinical and economic value to healthcare systems worldwide. Building on a legacy of product innovation and industry firsts, we continue to shape the orthopaedic landscape through advancements in medical technologies and digital surgery across the continuum of care to Keep People Moving today and tomorrow.
About Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity.
